Recently Updated Advisory Committee Materials

Recently Updated Advisory Committee Materials

Posted on February 28, 2012

Pharmaceutical Science and Clinical Pharmacology Advisory Committee

• Vinks_Disclosure Document for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-14KB)¹  (PDF - 19KB)
• Mager_Disclosure Document for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-14KB)²  (PDF - 19KB)
• 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-22KB)³  (PDF - 34KB)
• Capparelli_Disclosure Document for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-14KB)⁴  (PDF - 19KB)
• 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-157KB)⁵  (PDF - 168KB)
• Disclosure Document for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-14KB)⁶  (PDF - 19KB)
• Waivers for Conflicts of Interest for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology⁷
• 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-263KB)⁸  (PDF - 266KB)
• 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-249KB)⁹  (PDF - 252KB)
• 2012 Meeting Materials, Pharmaceutical Science and Clinical Pharmacology Advisory Committee¹⁰

-

Posted on February 27, 2012

Advisory Committee Calendar

• March 1-2, 2012 - Tobacco Products Scientific Advisory Committee Meeting Announcement¹¹

Gastrointestinal Drugs Advisory Committee

• Waivers for Conflicts of Interest for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee¹²
• Disclosure Document for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-16KB)¹³  (PDF - 13KB)
• 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-509KB)¹⁴  (PDF - 512KB)